The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review
Abstract
Background Selective serotonin-reuptake inhibitors (SSRIs) are increasingly being used as first-line therapy for severe premenstrual syndrome (PMS). We undertook a meta-analysis on the efficacy of SSRIs in this disorder.Methods We searched medical and scientific databases, approached pharmaceutical companies, and reviewed citations of relevant articles to identify 29 studies of the use of SSRIs in PMS. 14 were excluded (no placebo group, preliminary report of included trial, or low quality). 15 randomised placebo-controlled trials were included. Information on study design, participants, drugs used and dosing regimens, outcome measures, side-effects, and sources of funding was extracted. Standardised mean differences between treatment and placebo groups were calculated to obtain an overall estimate of efficacy. The primary outcome measure was a reduction in overall PMS symptoms.Findings The primary analysis included data on 904 women (570 assigned active treatment and 435 assigned placebo, including 101 in crossover trials). The overall standardised mean difference was -1.066 (95% CI -1.381 to -0.750), which corresponds to an odds ratio of 6.91 (3.90 to 12.2) in favour of SSRIs. SSRIs were effective in treating physical and behavioural symptoms. There was no significant difference in symptom reduction between continuous and intermittent dosing or between trials funded by pharmaceutical companies and those independently funded. Withdrawal due to side-effects was 2.5 times more likely in the active-treatment group than in the placebo group.Interpretation SSRIs are an effective first-line therapy for severe PMS. The safety of these drugs has been demonstrated in trials of affective disorder, and the side-effects at low doses are generally acceptable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The SSRIs fluoxetine, paroxetine, sertraline, escitalopram, and citalopram have been proven to reduce several premenstrual syndrome symptoms, although in some cases, side effects have also been reported with a dose-depended relationship [48,49].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [48]
In the citing paper
“Indeed, in these patients during the cure, no recurrent episodes of yeast infection were reported [48,50].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [48]
In the citing paper
“Interestingly, sertraline had also positive effects in women suffering from premenstrual syndrome and recurrent vulvovaginal candidiasis.”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [48]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840
Greene, R., & Dalton, K. (1953) · BMJ · doi:10.1136/bmj.1.4818.1007 · Cited by 1,819
Meta-analysis of screening and diagnostic tests.
Hasselblad, V., & Hedges, L. V. (1995) · Psychological Bulletin · doi:10.1037/0033-2909.117.1.167 · Cited by 579
Fluoxetine in the Treatment of Premenstrual Dysphoria
Steiner, M. S., Steinberg, S. I., Stewart, D. E., Carter, D., Berger, C., Reid, R. L., Grover, D., & Streiner, D. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322301 · Cited by 450
Progesterone metabolite allopregnanolone in women with premenstrual syndrome
RAPKIN, A., MORGAN, M., GOLDMAN, L., BRANN, D., SIMONE, D., & MAHESH, V (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00417-1 · Cited by 376
Research works printed but not linked: 1
- Rickels, 1990, Fluoxetine in the treatment of premenstrual syundrome, Curr Ther Res, 48, 161
Cited by
Sorted by citations
Items 301–364 of 364
Jorissen, B. L. (2003) · Research Publications (Maastricht University) · doi:10.26481/dis.20031217bj
Clinical Roundup: How Do You Treat Premenstrual Syndrome in Your Practice?
Simas, T. A. M., Byatt, N., & Deligiannidis, K. M. (2011) · Alternative and Complementary Therapies · doi:10.1089/act.2011.17401
Psychiatric disorders of menses, pregnancy, postpartum and menopause
Buist, A., Yonkers, K. A., & Craig, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.020
Vitamin B6 bei prämenstruellem Syndrom
Reinhard-Hennch, B., & Strowitzki, T. (2008) · Gynäkologische Endokrinologie · doi:10.1007/s10304-008-0260-y
Depression and the menstrual cycle
Frey, B. N., Minuzzi, L., Sassi, R. B., & Steiner, M. S. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.016
Disturbo disforico della fase luteale e sindrome premestruale
Nappi, R. E., Tonani, S., Santamaria, V., Ornati, A., Albani, F., Pisani, C., & Polatti, F. (2009) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2008.11.004
Guidelines for Clinical Management of Premenstrual Syndrome
Choi, D. S. (2005) · Journal of the Korean Medical Association · doi:10.5124/jkma.2005.48.5.465
Review: progesterone or progestogens lead to a marginal reduction in premenstrual syndrome symptoms
Yonkers, K. A. (2002) · Evidence-Based Mental Health · doi:10.1136/ebmh.5.2.56
Eriksson, E. (2002) · Evidence-based obstetrics and gynecology/Evidence-based obstetrics & gynecology · doi:10.1054/ebog.2002.0012
Premenstrual disphoric disorder: an update
Banti, S., Borri, C., Montagnani, Cargioli, C., Belli, S. R., Cotugno, B., Endicott, J., Oppo, A., & Mauri, M. (2012) · CINECA IRIS Institutial research information system (University of Pisa)
Pearlstein, T. B. (2006) · Women s Health · doi:10.2217/17455057.2.2.183
“, bupropion and desipramine) [7,13,14].”
Hautamäki, H. (2014) · Työväentutkimus Vuosikirja
UPPER UPPER UPPER UPPER UPPER RESPIRA RESPIRA RESPIRA RESPIRA RESPIRATORY
Tory, T., & Tract, T. (2007)
Gender, psychiatry and the rhetoric of science
Johnson, D. (2002)
Diagnostico y tratamiento del síndrome premenstrual
Solís, J. C. (2013) · Revista Médica de Costa Rica y Centroamérica
SSRIs for Severe Premenstrual Syndrome
Jarman, B. (2000) · Journal watch · doi:10.1056/jw200010170000002
Using the Good Pharmacy Practice Guidelines to advance patient safety
van der Gen, A. (2007)
HänggiBally, D. (2007) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2007.06313
Relationships, psychological distress and stigma: a counselling psychology perspective
Starnawski, Z. (2015) · City Research Online (City University London)
Internet Conversations About Premenstrual Dysphoria: A Content Analysis of PMDD Internet Forums
Regis, C. M. (2016) · The Atrium (University of Guelph)
Modulators of the GABAA receptor: novel therapeutic prospects
Thomsen, C., & Ebert, B. (2001) · CRC Press eBooks · doi:10.1201/9780203299388-26
PMDD: Definition and Prevalence
Pearlstein, T. B. (2004) · CNS Spectrums · doi:10.1017/s1092852900002005
Studies on Premenstrual Dysphoria
Eriksson, O. (2005) · Uppsala University Publications (Uppsala University)
The Effects of Sertraline on Premenstrual Tension Syndrome
Mk, M., El-Gharib, M. N., & As, D. (2017) · Journal of Basic and Clinical Reproductive Sciences
Associations between Plasma 25-Hydroxyvitamin D, Hormonal Contraceptives, and Premenstrual Symptoms
Jarosz, A. C. (2017) · TSpace (University of Toronto)
Review: selective serotonin reuptake inhibitors reduce symptoms in premenstrual syndrome
Smith, R. C. (2001) · Evidence-Based Mental Health · doi:10.1136/ebmh.4.2.43
Adopting the UNESCO Ethics Model to Critique Disease Mongering
Postol, B. (2016)
Analyzing cyclic patterns in psychological research_ a tutorialPreprint
Verboon, P., Leontjevas, R., Lataster, J., & van de Maat, R. (2018) · doi:10.31234/osf.io/zd5sn
Iakimova, R. K., Aptalidis, D., Pandova, M. S., Stoyanova, M. B., & Stoimenova-Popova, M. Y. (2019) · Journal of Biomedical and Clinical Research · doi:10.2478/jbcr-2019-0006
“Closer to our results is the data from a metaanalysis by Dimmock et al. (2000) [29].”
ResultSeifert‐Klauss, V., Prechtl, E., Land, C., Even, G., Funke, A. M., Hilgard, D., & Gerhad, I. (2006) · Elsevier eBooks · doi:10.1016/b978-343756260-0.50026-0
The Relationship Between Physical Activity and Premenstrual Syndrome in Female College StudentsPreprint
Chen, C. Y., Kawabe, R., Morino, S., Nagai‐Tanima, M., Aoyama, T., Mukaiyama, K., Shinohara, Y., Shimizu, H., Shimoura, K., & Kato, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1248368/v1
Current awareness in human psychopharmacology
(2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.272
Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1
Holsboer‐Trachsler, E., & Holsboer, F. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_28
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
Schwabe, U., & Rabe, T. (2003) · Springer eBooks · doi:10.1007/978-3-662-11173-4_26
holistic view of management of polycystic ovarian syndrome
Bhambhu, S., Burgujjar, M., Singh, V., Behmani, S., & Behmani, R. K. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.6011
Premenstrueel syndroom en SSRI's
(2001) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03057796
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_55
Schwabe, U., & Rabe, T. (2004) · Springer eBooks · doi:10.1007/978-3-642-18513-7_28
HänggiBally, D. (2007) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2007.06313
Hormonal interventions may provide relief of some of the symptoms of premenstrual syndrome
&NA; (2004) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200420010-00004
Specific psychiatric problems of women
Buckley, P., Prewette, D., Bird, J., & Harrison, G. (2004) · CRC Press eBooks · doi:10.1201/b13311-26
&NA; (2000) · Inpharma Weekly · doi:10.2165/00128413-200012580-00028
Schwabe, U., & Rabe, T. (2004) · Springer eBooks · doi:10.1007/978-3-642-18512-0_26
Schwabe, U., & Rabe, T. (2001) · Springer eBooks · doi:10.1007/978-3-642-56434-5_26
Hirsch, E., Benda, M. S., Garvey, R. W., & Roy, A. K. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-24926-6_11
PREMENSTRUAL SYNDROME: BASIC APPROACHES TO TREATMENT
Kiek, M. A. (2023) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2023-4-21-37
Known Methods to Relieve Symptoms of Premenstrual Syndrome (PMS): A Review
Machała-Ćwikła, E., Łapińska, U., Zdziebło, P., Ćwikła, P., Machała, K., & Machała, D. (2024) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2024.161301
Chapter 13. Sertraline and Paroxetine
Howlett, J. R., & Schatzberg, A. F. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as13
A Literature Review on Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Mane, S. S. M. S. S., Karne, L. S., Devade, O. A., Purane, L. M., & Redasani, V. K. (2025) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2025.00007
The difference between subjective symptoms and objective symptom of edema during the menstrual cycle
Takano, Y., Shirai, T., Tanaka, Y., Sakamoto, K., Yokota, H., Hirabayashi, R., Ishigaki, T., Komiya, M., & Edama, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-55554-1
“Furthermore, the intensity of subjective symptoms is believed to be influenced by psychological factors, and fluctuations in hormone levels are reportedly strongly associated with emotional changes and sensitivity to bodily sensations 28,29 .”
Estrogens and Other Hormones in the Treatment of Premenstrual Syndromes
Born, L., & Steiner, M. S. (2005) · Springer eBooks · doi:10.1007/3-211-27063-9_8
“First line therapy is still low-dose selective serotonin reuptake inhibitors, which have demonstrated efficacy with minimal side effects (Dimmock et al. 2000; Born and Steiner 2001).”
BackgroundSasai, S., Nishikawa, M., Matsushima, Y., Matsuyama, H., Osawa, M., Uiji, S., Nakamoto, I., Ajiki, S., Ogawa, S., Masutani, E., et al. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04439-6
“Although selective serotonin reuptake inhibitors [11] and oral contraceptives (OCs) [12] are sometimes indicated for severe PMS, the following challenges remain.”
Tiwari, A., Lu, D., Chocano-Bedoya, P. O., & Bertone-Johnson, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00024-x
Reproductive Life Cycle and Depression in Women
Kim, K.-M., & Jung, Y. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_4
PREMENSTRUAL DYSPHORIC DISORDER (PMDD): CURRENT PHARMACOTHERAPY AND EMERGING TREATMENT APPROACHES
Oziębło, J., Kijowska, M., Klusek, K., Batory, M., Jakubowski, J., Kraska, K., Krasucka, N., Zynkowska, A., Skrzyniarz, A. M., & Kiełbus, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6100
Psychotropic Drugs: A Promising Non‐Antibiotic Agent to Combat Multi‐Drug‐Resistant Microorganisms
Singh, I. P., Singh, H., Sharma, D., Keshri, A., Gaurav, N., Dhakad, M. S., & Beg, M. M. A. (2026) · Drug Development Research · doi:10.1002/ddr.70380
“Innumerable reports on SSRIs (sertraline, fluoxetine, paroxetine, citalopram, and escitalo-pram) were found to be beneficial in decreasing many symptoms associated with premenstrual syndrome (Dimmock et al. 2000; Marjoribanks et al. 2013).”
Zespół napięcia przedmiesiączkowego i przedmiesiączkowe zaburzenia dystroficzne
Pilińska, A., & Przestrzelska, M. (2019) · doi:10.82051/mnph-2019-1206
Leysen, B., & Roumen, F. J. M. E. (2013) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8267-5_11
Estrogen Therapy: Interface Between Gynecology and Psychiatry
ISMAIL, K. M. K., Sunanda, G. V., & O’Brien, P. M. S. (2005) · Springer eBooks · doi:10.1007/3-211-27063-9_14
Self-citationSerotonin-selektive Antidepressiva(SSRI, DSA)
Laux, G., Eckert, A., Müller, W. E. G., Breyer-Pfaff, U., Kasper, S. F., Riedel, M. J., Müller, N., Möller, H., Hiemke, C., Schoechlin, C., et al. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_4
Zijn dydrogesteron en vitamine B6-medicatie effectief bij de behandeling van postpartumdepressies?
van Leeuwen, J. S. (2006) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8808-0_603
Metadata
- Authors
- Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S.
- Affiliations
- University Hospitals of North Midlands NHS Trust (GB)
- Keele University (GB)
- Corresponding author
- Dimmock, Paul W
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 356
- Issue
- 9236
- Pages
- 1131-1136
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2119435034
- Cited by
- 368
- References
- 47
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 6 · 2023: 10 · 2022: 11 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 16 · 2015: 14 · 2014: 11 · 2013: 13 · 2012: 10
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- selective serotonin reuptake inhibitors, premenstrual syndrome, drug efficacy, pharmaceutical industry funding, adverse drug reactions, first-line therapy
- MeSH terms
- Female, Humans, Patient Dropouts, Premenstrual Syndrome, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
